A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome

Condition:   Angelman Syndrome Intervention:   Drug: GTX-102 Sponsors:   GeneTX Biotherapeutics, LLC;   Ultragenyx Pharmaceutical Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials